Lv6
1830 积分 2024-06-17 加入
SLC6A14-mediated carnitine transmembrane uptake from PPARγ + cancer-associated fibroblasts promotes recurrence of pancreatic cancer
28天前
已完结
SLC6A14-mediated carnitine transmembrane uptake from PPARγ + cancer-associated fibroblasts promotes recurrence of pancreatic cancer
1个月前
已完结
Emerging nanoparticle-based therapies for pancreatic cancer: Current clinical landscape
3个月前
已完结
Clinical and pathological factors associated with survival in patients with pancreatic cancer who receive adjuvant therapy after neoadjuvant therapy: A retrospective multi-institutional analysis
3个月前
已完结
Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study
3个月前
已完结
β-catenin plus PROX1 immunostaining stratifies disease progression and patient survival in neoadjuvant-treated pancreatic cancer
3个月前
已完结
Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected Pancreatic Cancer
3个月前
已完结
The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion
3个月前
已完结
Pancreatic cancer
5个月前
已完结
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
8个月前
已完结
皖公网安备34019202002308
